Oncology Research Open Access
Home Oncology Research All Issues Volume 34 Issue 5
Volume 34 Issue 5, April 2026
Review | Open Access
Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer
Published: 22 April 2026
2026, 34(5): 1
Review | Open Access
The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer
Published: 22 April 2026
2026, 34(5): 2
Review | Open Access
Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Meta-Analysis of All Randomized Clinical Trials with Subgroup Analysis by Patient Profile
Published: 22 April 2026
2026, 34(5): 3
Review | Open Access
AI-Guided Discovery of Oncogenic Signaling Crosstalk in Tumor Progression and Drug Resistance
Published: 22 April 2026
2026, 34(5): 4
Review | Open Access
Cancer-Associated Arterial Thrombosis: Mechanisms and Risk Factors
Published: 22 April 2026
2026, 34(5): 5
Review | Open Access
Melatonin in Integrative Oncology: Biological Mechanisms, Therapeutic Evidence and Implementation Strategies
Published: 22 April 2026
2026, 34(5): 6
Review | Open Access
Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia
Published: 22 April 2026
2026, 34(5): 7
Review | Open Access
Extrachromosomal DNA in Solid Tumors—Landscape, Immune Effects, and Resistance to Targeted Therapy
Published: 22 April 2026
2026, 34(5): 8
Review | Open Access
Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology
Published: 22 April 2026
2026, 34(5): 9
Review | Open Access
In Vivo CAR-T Therapy for Cancer Treatment: Mechanisms, Technological Advances, and Clinical Translation
Published: 22 April 2026
2026, 34(5): 10
Review | Open Access
Multidimensional Regulatory Network of YAP1 Driving Malignant Progression in Esophageal Cancer: Molecular Mechanisms and Targeted Therapy: A Review
Published: 22 April 2026
2026, 34(5): 11
Review | Open Access
Navigating the Tumor Microenvironment in Colorectal Liver Metastasis: Barriers to Therapy and Emerging Opportunities
Published: 22 April 2026
2026, 34(5): 12
Article | Open Access
Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival
Published: 22 April 2026
2026, 34(5): 13
Article | Open Access
Data Mining for Identification of Targets and Repurposed Drugs to Eliminate Persistent Chronic Myeloid Leukaemia Stem Cells: Targeting RAS/RAF Signalling
Published: 22 April 2026
2026, 34(5): 14
Article | Open Access
Comparative Analysis of Tumor Microbiota Identifies a Metastatic-Specific Bacterial Signature, Highlighting Streptococcus spp. As the Predominant Hub across Cancers
Published: 22 April 2026
2026, 34(5): 15
Article | Open Access
Glutathione Peroxidases 1 and 3 Immunoscores in Clear Cell Renal Cell Carcinoma: New Insights from a Case-Series Study
Published: 22 April 2026
2026, 34(5): 16
Article | Open Access
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study
Published: 22 April 2026
2026, 34(5): 17
Article | Open Access
Integrated Global Phosphoproteomic, Bioinformatic, and Machine Learning Analysis Reveals Regulatory Networks of TOP1, TOP2A, TOP2B, and C1orf35 in Hepatocellular Carcinoma (HCC)
Published: 22 April 2026
2026, 34(5): 18
Article | Open Access
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
Published: 22 April 2026
2026, 34(5): 19
Article | Open Access
CDKN1A/p21 Influences the Survival and Expansion of Breast Cancer Stem Cells after Oxidative Damage
Published: 22 April 2026
2026, 34(5): 20
Article | Open Access
Mebendazole Attenuates Cellular Invasion in a 3D Culture Model of Meningioma by Disrupting Rho-GTPase-Mediated Microtubule Function
Published: 22 April 2026
2026, 34(5): 21
Article | Open Access
Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions
Published: 22 April 2026
2026, 34(5): 23
Article | Open Access
Machine Learning (ML) and Molecular Dynamics–Driven Optimization of VEGFR2 Ligands against Hepatocellular Carcinoma
Published: 22 April 2026
2026, 34(5): 24
Article | Open Access
Plexin A2 Knockdown Enhances Apoptosis in Chemotherapy Treated Melanoma Cells
Published: 22 April 2026
2026, 34(5): 28
Article | Open Access
Targeting Oncogenic lncRNA KRT7-AS to Induce Ferroptosis Suppresses Ovarian Cancer Progression
Published: 22 April 2026
2026, 34(5): 29
Article | Open Access
Identify MTDH as a Key Gene of Radio-Resistance in Colorectal Cancer Based on Multi-Omics and Experimental Validation
Published: 22 April 2026
2026, 34(5): 30
Article | Open Access
Regulation of Histone Emulsification by HPDL via LDHA/LDHB Promotes EC Cell Proliferation
Published: 22 April 2026
2026, 34(5): 31
Article | Open Access
CDCA7 Promotes Proliferation and Suppresses Apoptosis in Gastric Cancer via HELLS-Mediated Chromatin Remodeling
Published: 22 April 2026
2026, 34(5): 32
Article | Open Access
Circ72688 Drives Breast Cancer Invasion and Metastasis via the miR-654-5p/ORAI2 Axis
Published: 22 April 2026
2026, 34(5): 33
Article | Open Access
SLC16A1 Activates the STAT3/SLC7A11 Pathway to Mediate Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma
Published: 22 April 2026
2026, 34(5): 34
Article | Open Access
Elucidating the Potential Targets and Mechanisms of Bisphenol A-Induced Prostate Cancer Based on Network Toxicology and Molecular Docking Analyses
Published: 22 April 2026
2026, 34(5): 35
Article | Open Access
Isoliquiritigenin Impedes Breast Cancer Progression through PITX1–PFKP-Mediated Glycolysis Reprogramming
Published: 22 April 2026
2026, 34(5): 36
Case Report | Open Access
Case Report: A Case of Neuroendocrine Carcinoma of the Endometrium with Deficient DNA Mismatch Repair Had Achieved Clinical Complete Response after Combination Therapy
Published: 22 April 2026
2026, 34(5): 37
Retraction | Open Access
Retraction: MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1
Published: 22 April 2026
2026, 34(5): 38
Retraction | Open Access
Retraction: miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2
Published: 22 April 2026
2026, 34(5): 39
Retraction | Open Access
Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Published: 22 April 2026
2026, 34(5): 40